Practice/Facility Profile
Physician Directory
About Us
Contact Us
User ID & Password Management
Help
TRICARE
Bookmark this site
Patient Eligibility
Patient Personal Health Records
Claim Status
Claim Submission
Claim Estimator
Claim Reconsideration
Claim Research Project
Electronic Claims Submission (EDI)
Electronic Payments & Statements (EPS)
Fee Schedule Lookup
UnitedHealthcare Online All-Payer Gateway
Referral Status
Referral Submission
Notification Status
Notification Submission
Radiology Notification Submission & Status
Prescription Solutions Prior Authorization Submission & Status
Health Information Technology
Health Literacy & Cultural Competency
Health Resources for Patients
News
Pharmacy Resources
Policies & Protocols
Reports
Products & Services
Scorecard
Training & Education
Welcome Kit for New Physicians and Providers
Cancer - Oncology
Cardiology
Care Management
Geriatric Resources
Neuroscience, Orthopaedic & Spine
Patient Safety Resources
Performance Measurement & Reporting
Primary Care and ER Care Management
Radiology
UnitedHealth Premium
Womens Health
Patient Eligibility & Benefits
Claims & Payments
Notifications
Tools & Resources
Clinician Resources
Welcome,
Phyllis Reilly
Logout
My Account
Not Phyllis?
Home
>
Help
>
Frequently Asked Questions (FAQs)
>
Herceptin Drug Policy
Herceptin Drug Policy
Printer Friendly Page
FAQs
Return to Top
If an enrollee has been receiving Herceptin in the past, will the physician office need to submit a copy of the pathology report?
What is Herceptin?
What is the new policy regarding Herceptin?
What is the process for the submission of a pathology report?
What testing will UnitedHealthcare use to determine if a tumor is over expressing the HER2 protein?
Who may I contact for assistance?
Why the change in the UnitedHealthcare Drug policy for Herceptin?
Security Notice
Privacy Policy
Notice of Privacy Policy & Practices
Site Use Agreement
Site Map
Copyright 2009 UnitedHealth Group Incorporated. All rights reserved
.
Search:
